INMD Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 birž. 2024 @ 23:00):
Our systems believe the stock currently is undervalued by 0.13% compare to its pairs and should correct upwards.

Stats
Šios dienos apimtis	3.38M
Vidutinė apimtis	1.30M
Rinkos kapitalizacija	1.54B
EPS	$0.280 ( Q1 \| 2024-05-02 )
Kita pelno data	( $0.440 ) 2024-07-25
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	8.64 (Sector) 42.63 (Industry) 0
ATR14	$0.0170 (0.09%)

AEMD -13.81%

AFIB -13.41%

AHCO 1.42%

AHPI 0.00%

ALGN -0.65%

ANIK -1.52%

APEN 0.00%

APYX -4.96%

ARAY 1.68%

ATEC 0.58%

AXDX 1.74%

AXGN 0.28%

AXNX -0.25%

AZYO 2.05%

BBLG 0.83%

BIOL 38.50%

BJDX -6.77%

BMRA -2.16%

BRKR -0.61%

BSGM -5.35%

BWAY 0.83%

CERS 0.57%

CFMS 0.44%

CLPT -5.11%

CODX -1.57%

CSII 0.15%

CTKB 1.64%

CTSO -9.00%

CUTR 3.42%

CVRX 2.48%

DCTH 1.70%

DXCM -1.01%

DYNT -20.97%

EAR -4.10%

ECOR -0.16%

EDAP 4.21%

ESTA 3.56%

FONR 1.46%

HJLI -1.98%

HSDT -1.99%

HSKA 0.00%

HYPR -11.00%

IART 1.36%

ICAD 0.00%

ICCM -1.99%

IINN -2.13%

INGN 2.01%

INMD 1.00%

IRIX 0.00%

IRMD -0.05%

IRTC 3.12%

ISO 0.00%

ITMR 0.00%

KIDS -0.10%

LHDX 0.00%

LIVN -0.02%

LNSR 2.74%

LUCD -5.64%

LUNG 2.76%

MASS 0.00%

MDGS 10.28%

MOTS 0.17%

MOVE -3.51%

MSON 0.00%

NAOV -5.41%

NARI 2.47%

NMRD 0.00%

NNOX 10.71%

NPCE 8.00%

NTUS 0.00%

NURO 0.27%

NUVA -2.24%

NUWE 18.57%

NVCN 0.00%

NVNO 1.55%

OBLN -5.86%

OFIX -1.63%

OM -7.00%

PACB 0.74%

PAVM 6.30%

PETV 0.00%

PODD -2.50%

PRCT 2.28%

PROF -4.88%

QIPT 3.54%

QTRX 1.62%

RCEL -0.38%

RPID -4.90%

RSLS -3.23%

RWLK 6.07%

RXST 1.81%

SGHT 1.99%

SIBN 4.02%

SIEN -18.69%

SILK 0.52%

SINT -6.98%

SOLY 0.00%

SRDX 0.17%

SRGA 0.00%

SRTS 1.72%

SWAV 0.00%

TBIO -8.29%

TCMD 3.20%

TELA -8.56%

THMO 9.52%

TIVC -1.02%

TLIS 0.72%

TMCI 0.15%

TMDI 0.00%

TMDX 1.89%

TNDM -0.35%

TNON 0.00%

UFPT 2.41%

VERO -2.71%

VIVE 0.00%

VMD 1.24%

VRAY 0.00%

VREX 0.75%

VVOS -7.11%

XAIR -7.38%

XENT 0.00%

ZIMV 3.75%

Insider Trading

Date	Person	Action	Amount	type
2012-09-20	Sagard Capital Partners, L.p.	Buy	1 000	Common Stock
2012-09-20	Howe Michael C	Sell	5 556	Common Stock
2012-06-10	Sagard Capital Partners, L.p.	Sell	0	Common Stock
2012-01-03	Howe Michael C	Buy	5 556	Common Stock
2011-08-24	Howe Michael C	Buy	0

INSIDER POWER
0.00
Last 99 transactions
Buy: 2 558 547 \| Sell: 23 556

Koreliacija (AI algo v.1.1b): Undervalued: 0.13% $18.26 paired level. (Algoritmas realiuoju laiku stebi didžiausią koreliaciją turinčių akcijų pokyčius ir suteikia momentinę informaciją)

Tūris Koreliacija

Ilgas: -0.21 (neutral)

Trumpas: 0.18 (neutral)

Signal:(51.36) Neutral

Inmode Ltd Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
HAIN	0.902
ADBE	0.894
SAGE	0.891
INTA	0.891
EMKR	0.884
LUCD	0.88
FRHC	0.877
BSBK	0.876
PDCO	0.872
ZD	0.872

10 Labiausiai neigiamai susiję koreliacijos
PPTA	-0.907
STAA	-0.905
IGLD	-0.888
PWP	-0.886
BRY	-0.881
CENX	-0.877
HYMC	-0.873
BLIN	-0.871
GALT	-0.868
FANG	-0.863

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Inmode Ltd Koreliacija - Valiuta/Žaliavos

0.56
( weak )

0.36
( neutral )

0.00
( neutral )

0.12
( neutral )

0.00
( neutral )

-0.50
( neutral )

Inmode Ltd Finansinės ataskaitos

Annual	2023
Pajamos:	$492.05M
Bruto pelnas:	$411.34M (83.60 %)
EPS:	$2.37

FY	2023
Pajamos:	$492.05M
Bruto pelnas:	$411.34M (83.60 %)
EPS:	$2.37

FY	2022
Pajamos:	$454.27M
Bruto pelnas:	$380.79M (83.82 %)
EPS:	$1.960

FY	2021
Pajamos:	$357.57M
Bruto pelnas:	$303.97M (85.01 %)
EPS:	$2.03

Financial Reports:

No articles found.

Inmode Ltd Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Inmode Ltd

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.